Sfoglia per Autore MACOR, PAOLO
Detection of mRNA for the terminal complement components C5, C6, C8 and C9 in human umbilical vein endothelial cells in vitro.
2001-01-01 H., Langeggen; K. E., Berge; Macor, Paolo; Fischetti, Fabio; F., Tedesco; G., Hetland; K., Berg; E., Johnson
The cleavage site of C5 from man and animals as a common target for neutralizing human monoclonal antibodies: in vitro and in vivo studies
2002-01-01 Marzari, Roberto; Sblattero, Daniele; Macor, Paolo; Fischetti, Fabio; Gennaro, Renato; Marks, Jd; Bradbury, A.; Tedesco, Francesco
Thrombus formation induced by antibodies to beta2-glycoprotein I is complement dependent and requires a priming factor.
2005-01-01 Fischetti, Fabio; Durigutto, Paolo; Pellis, Valentina; Debeus, Alessandra; Macor, Paolo; Bulla, Roberta; Bossi, Fleur; Ziller, Federica; Sblattero, Daniele; Meroni, P.; Tedesco, Francesco
Controlling complement resistance in cancer by using human monoclonal antibodies that neutralize complement-regulatory proteins CD55 and CD59
2005-01-01 Ziller, Federica; Macor, Paolo; Bulla, Roberta; Sblattero, Daniele; Marzari, Roberto; Tedesco, Francesco
Complement activated by chimeric anti-folate receptor antibodies is an efficient effector system to control ovarian carcinoma.
2006-01-01 Macor, Paolo; Mezzanzanica, D; Cossetti, C; Alberti, P; Figini, M; Canevari, S; Tedesco, Francesco
The seventh complement component is expressed on endothelial cells membrane and exerts an anti-inflammatory action
2007-01-01 Bossi, Fleur; Rizzi, Lucia; Bulla, Roberta; Radillo, Oriano; Agostinis, Chiara; Debeus, Alessandra; Macor, Paolo; DE SETA, Francesco; Wurzner, Reinhard; Tedesco, Francesco
Complement as effector system in cancer immunotherapy.
2007-01-01 Macor, Paolo; Tedesco, Francesco
Selective therapeutic control of C5a and the terminal complement complex by anti-C5 single-chain Fv in an experimental model of antigen-induced arthritis in rats.
2007-01-01 Fischetti, Fabio; Durigutto, Paolo; Macor, Paolo; Marzari, Roberto; Carretta, Renzo; Tedesco, Francesco
In vivo targeting of human neutralizing antibodies against CD55 and CD59 to lymphoma cells increases the antitumor activity of rituximab.
2007-01-01 Macor, Paolo; Tripodo, C; Zorzet, Sonia; Piovan, E; Bossi, Fleur; Marzari, Roberto; Amadori, A; Tedesco, Francesco
Posttransplant ischemia-reperfusion injury in transplanted heart is prevented by a minibody to the fifth component of complement.
2008-01-01 Ferraresso, M; Macor, Paolo; Valente, M; Della Barbera, M; D'Amelio, F; Borghi, O; Raschi, E; Durigutto, P; Meroni, P; Tedesco, Francesco
Complement C1q and C8beta deficiency in an individual with recurrent bacterial meningitis and adult-onset systemic lupus erythematosus-like illness.
2008-01-01 Pickering, M. C.; Macor, Paolo; Fish, J.; Durigutto, Paolo; Bossi, Fleur; Petry, F.; Botto, M.; Tedesco, Francesco
In vivo biodistribution and lifetime analysis of cy5.5-conjugated rituximab in mice bearing lymphoid tumor xenograft using time-domain near-infrared optical imaging.
2008-01-01 Biffi, S; Garrovo, C; Macor, Paolo; Tripodo, C; Zorzet, Sonia; Secco, E; Tedesco, Francesco; Lorusso, V.
An update on the xenograft and mouse models suitable for investigating new therapeutic compounds for the treatment of B-cell malignancies.
2008-01-01 Macor, Paolo; Secco, E; Zorzet, Sonia; Tripodo, C; Celeghini, Claudio; Tedesco, Francesco
Complement in human diseases: Lessons from complement deficiencies.
2009-01-01 Botto, M; Kirschfink, M; Macor, Paolo; Pickering, Mc; Würzner, R; Tedesco, Francesco
Selection and characterization of a novel agonistic human recombinant anti-TRAIL-R2 minibody with anti-leukemic activity.
2009-01-01 Secchiero, P; Sblattero, Daniele; Chiaruttini, C; Melloni, E; Macor, Paolo; Zorzet, Sonia; Tripodo, C; Tedesco, Francesco; Marzari, Roberto; Zauli, G.
C7 is expressed on endothelial cells as a trap for the assembling terminal complement complex and may exert anti-inflammatory function.
2009-01-01 Bossi, Fleur; Rizzi, L.; Bulla, Roberta; Debeus, A.; Tripodo, C.; Picotti, P.; Betto, E.; Macor, Paolo; Pucillo, C.; Würzner, R.; Tedesco, Francesco
P-selectin glycoprotein ligand-1 as a potential target for humoral immunotherapy of multiple myeloma.
2009-01-01 Tripodo, C; Florena, Am; Macor, Paolo; Di Bernardo, A; Porcasi, R; Guarnotta, C; Ingrao, S; Zerilli, M; Secco, E; Todaro, M; Tedesco, Francesco; Franco, V.
Humoral immunotherapy of multiple myeloma: perspectives and perplexities.
2010-01-01 Di Bernardo, A; Macor, Paolo; Guarnotta, C; Franco, G; Florena, Am; Tedesco, Francesco; Tripodo, C.
Exploratory study on the effects of biodegradable nanoparticles with drugs on malignant B cells and on a human/mouse model of Burkitt lymphoma.
2010-01-01 Marín, G. H.; Mansilla, E.; Mezzaroba, N.; Zorzet, Sonia; Núñez, L.; Larsen, G.; Tau, J. M.; Maceira, A.; Spretz, R.; Mertz, C.; Ingrao, S.; Tripodo, C.; Tedesco, Francesco; Macor, Paolo
Simple scale-up of recombinant antibody production using an UCOE containing vector
2011-01-01 Boscolo, S; Mion, F; Licciulli, M; Macor, Paolo; De Maso, L; Brce, M; Antoniou, Mn; Marzari, Roberto; Santoro, C; Sblattero, Daniele
Legenda icone
- file ad accesso aperto
- file disponibili sulla rete interna
- file disponibili agli utenti autorizzati
- file disponibili solo agli amministratori
- file sotto embargo
- nessun file disponibile